PMV Pharmaceuticals
PMVP
PMVP
104 hedge funds and large institutions have $333M invested in PMV Pharmaceuticals in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 41 increasing their positions, 33 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
104
Holders Change
-2
Holders Change %
-1.89%
% of All Funds
1.66%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
8
Increased
41
Reduced
33
Closed
10
Calls
$3.98M
Puts
$1.61M
Net Calls
+$2.38M
Net Calls Change
+$2.28M
Top Buyers
| 1 |
PHS
1
PFM Health Sciences
San Francisco,
California
|
$7.95M |
| 2 |
2
Alkeon Capital Management
New York
|
$14.4M |
| 3 |
TLP
3
Tri Locum Partners
New York
|
$5.04M |
| 4 |
OCA
4
Octagon Capital Advisors
New York
|
$5.55M |
| 5 |
GTC
5
Ghost Tree Capital
New York
|
$4.33M |
